Alyeska Investment Group
INSP icon

Alyeska Investment Group’s Inspire Medical Systems INSP Stock Holding History

Alyeska Investment Group’s Portfolio INSP Stock Details INSP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-87,687
Closed -$17.8M – 536
2023
Q4 		$17.8M Buy
+87,687
New +$14.2M 0.12% 217
2021
Q2 		– Sell
-3,220
Closed -$667K – 778
2021
Q1 		$667K Buy
+3,220
New +$684K 0.01% 641

Other funds holding INSP

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return
FCM
Frontier Capital Management Boston, Massachusetts $9.73B AUM 55.65% 1-Year Est. Return
CIP
Champlain Investment Partners Burlington, Vermont $7.88B AUM 6.82% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return

Alyeska Investment Group's INSP Position: Q1 2024 in Review

Alyeska Investment Group sold out of Inspire Medical Systems (INSP) in Q1 2024, closing a stake of 87,687 shares — an estimated $17.8M sold.

Alyeska Investment Group first reported a position in INSP in Q1 2021 and held it in 2 quarters. The position peaked at $17.8M in Q4 2023. 328 funds tracked by Wall St. Rank hold INSP as of Q1 2024.

  • Alyeska Investment Group reported no remaining Inspire Medical Systems position as of Q1 2024 after selling out during the quarter.
  • Alyeska Investment Group sold 87,687 Inspire Medical Systems shares in Q1 2024, an estimated $17.8M.
  • Alyeska Investment Group first reported a position in Inspire Medical Systems in Q1 2021 and held it in 2 quarters.
  • Alyeska Investment Group's Inspire Medical Systems position peaked at $17.8M in Q4 2023.
  • 328 funds tracked by Wall St. Rank held Inspire Medical Systems as of Q1 2024.

Based on Alyeska Investment Group's 13F filing for Q1 2024, filed 15 May 2024.